6th Dermatology Drug Development Summit Europe

The Dermatology Drug Development Summit Europe returns for its 6th year as the premier industry forum dedicated to advancing next-generation immunodermatology therapies. With regulatory breakthroughs reshaping the landscape-such as Eli Lilly’s IL-13 inhibitor and LEO Pharma’s topical JAK-I-2024 was a pivotal year for the industry to accelerate innovation.

Join 80+ senior leaders from Sanofi, Alys Pharmaceuticals, Moonlake Immunotherapeutics, and more to ensure 2025 breaks new records for the industry!

Time: 8:00 AM – 4:15 PM

Venue details: Hotel Palace Berlin, 45 Budapester Straße, Berlin, 10787, Germany

Prices:
Conference Only – Industry Pricing: EUR 2799.00,
Conference Only – Academic Pricing: EUR 2399.00,
Conference Only – Vendor Pricing: EUR 3499.00

Speakers: Ana Rossi, Global Senior Medical Director, Immunology, Sanofi, Carlo Pincelli, Chief Medical Officer, PinCell, Cheri Ackerman, Co-Founder and CEO, Concerto Biosciences, Daniel Brownell, Senior Director, R AND D, AOBiome, Ehsanollah Esfandiari, Global Head, Immunology R AND D, Kyowa Kirin, Eric Meldrum, Chief Scientific Officer, Citryll Therapeutics, Hana Cernecka, Managing director, EB Research Institute, Hannah Cummings, Senior Director, Medical Affairs, Kyowa Kirin, and more